Finnish Defense Forces Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2005
NCT00973583
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Finnish Defense Forces

Active Ingredients

Drugs in Phase 3 Trials (1)

lactobacillus delbrueckii (1 trial)

Drugs in Other Trials (1)

vitamin d3 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Digestive System Diseases (Phase 3)

Gastrointestinal Diseases (Phase 3)

Infections (Phase 3)

Respiratory Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2